SYSTEMATIC REVIEW article
Front. Cell Dev. Biol.
Sec. Signaling
This article is part of the Research TopicNeural Signaling in Psychiatric Disorders: Mechanisms and InsightsView all 3 articles
Bioenergetic Impairment in Schizophrenia: Role of Mitochondrial Signaling in Synaptic Dysfunction - A Systematic Review
Provisionally accepted
- 1San Luigi Gonzaga University Hospital, Orbassano, Italy
- 2Universita degli Studi Gabriele d'Annunzio Chieti Pescara, Chieti, Italy
- 3Universita degli Studi di Torino, Turin, Italy
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
ABSTRACT Background: Mitochondrial dysfunction represents a critical pathophysiological mechanism in schizophrenia, potentially linking bioenergetic impairment to synaptic dysfunction and cognitive deficits. Converging evidence suggests that deficits in oxidative phosphorylation may drive the synaptic pathology contributing to treatment-resistant cognitive and negative symptoms. Objective: To systematically review the evidence linking mitochondrial bioenergetic dysfunction to synaptic impairment in schizophrenia, examining structural, functional, and molecular mechanisms across multiple methodological approaches. Methods: Following PRISMA guidelines, we searched PubMed/MEDLINE, Embase, PsycINFO, and Web of Science from 2000-2025 for original research studies investigating mitochondrial function and synaptic dysfunction in schizophrenia. Two independent reviewers screened 2,224 articles, with 29 studies meeting inclusion criteria. Quality was assessed using the Newcastle-Ottawa Scale (median score 7/9). Results: Twenty-nine studies representing 2,847 participants demonstrated consistent mitochondrial dysfunction across postmortem (n=10), neuroimaging (n=8), and molecular/cellular (n=11) investigations. Postmortem studies revealed reduced complex I (18-35%) and complex IV activity (22-28%) in prefrontal cortex, with concurrent synaptic density reductions (27%). Neuroimaging studies demonstrated 20-22% reductions in ATP synthesis rates correlating with cognitive deficits (r=0.48) and negative symptoms (r=- 0.42). First-episode antipsychotic-naïve patients exhibited comparable bioenergetic abnormalities, indicating primary pathophysiology rather than medication effects. Molecular studies identified impaired calcium homeostasis, oxidative stress (27-35% glutathione reductions in synaptic compartments), and novel pseudogene regulatory mechanisms perpetuating complex I deficits. Peripheral biomarkers including platelet complex I activity and cell-free mitochondrial DNA showed disease specificity and correlation with cognitive impairment. Substantial methodological heterogeneity precluded meta-analysis but provided complementary evidence across analytical levels. Conclusions: Mitochondrial bioenergetic impairment represents a core, potentially modifiable pathophysiological mechanism driving synaptic dysfunction in schizophrenia. Regional specificity (prefrontal cortex, hippocampus) and cell-type selectivity (pyramidal neurons) provide mechanistic insights into cognitive symptom profiles. Early presence and progressive worsening suggest critical intervention windows. Mitochondrial-targeted therapies merit investigation as novel approaches for treatment-resistant cognitive and negative symptoms.
Keywords: Bioenergetics, First-episode psychosis, Mitochondrial dysfunction, Oxidative Phosphorylation, Schizophrenia, synaptic dysfunction
Received: 05 Nov 2025; Accepted: 23 Jan 2026.
Copyright: © 2026 RICCI, Martinotti, Mosca and Maina. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: VALERIO RICCI
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.